These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1607335)

  • 21. Estimation of glomerular filtration rate to adjust vancomycin dosage in critically ill patients: superiority of the Chronic Kidney Disease Epidemiology Collaboration equation?
    Conil JM; Georges B; Breden A; Ruiz S; Cougot P; Fourcade O; Saivin S
    Anaesth Intensive Care; 2014 Mar; 42(2):178-84. PubMed ID: 24580382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of Decision Support Implementation in Emergency Department Vancomycin Dosing.
    Faine B; Mohr N; Harland KK; Rolfes K; Porter B; Fuller BM
    West J Emerg Med; 2015 Jul; 16(4):557-64. PubMed ID: 26265968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
    Denetclaw TH; Dowling TC; Steinke D
    Ann Pharmacother; 2013 Dec; 47(12):1611-7. PubMed ID: 24259632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.
    Cristallini S; Hites M; Kabtouri H; Roberts JA; Beumier M; Cotton F; Lipman J; Jacobs F; Vincent JL; Creteur J; Taccone FS
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4750-6. PubMed ID: 27216073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
    van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
    Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.
    Fernández de Gatta MM; Fruns I; Domínguez-Gil A
    Pharmacotherapy; 1994; 14(2):196-201. PubMed ID: 8197039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a dosing regimen for continuous vancomycin infusion in critically ill patients: an observational study in intensive care unit patients.
    Saugel B; Gramm C; Wagner JY; Messer M; Lahmer T; Meidert AS; Schmid RM; Huber W
    J Crit Care; 2014 Jun; 29(3):351-5. PubMed ID: 24456810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin dosing for pneumonia in critically ill trauma patients.
    Patanwala AE; Norris CJ; Nix DE; Kopp BJ; Erstad BL
    J Trauma; 2009 Oct; 67(4):802-4. PubMed ID: 19820588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in vancomycin pharmacokinetics in critically ill infants.
    Gous AG; Dance MD; Lipman J; Luyt DK; Mathivha R; Scribante J
    Anaesth Intensive Care; 1995 Dec; 23(6):678-82. PubMed ID: 8669599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
    Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of serum cystatin C to determine the dose of vancomycin in critically ill patients.
    Suzuki A; Imanishi Y; Nakano S; Niwa T; Ohmori T; Shirai K; Yoshida S; Furuta N; Takemura M; Ito H; Ieiri I; Seishima M; Ogura S; Itoh Y
    J Pharm Pharmacol; 2010 Jul; 62(7):901-7. PubMed ID: 20636878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
    Medellín-Garibay SE; Romano-Moreno S; Tejedor-Prado P; Rubio-Álvaro N; Rueda-Naharro A; Blasco-Navalpotro MA; García B; Barcia E
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
    Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
    Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
    Rokas KE; Johnson JW; Beardsley JR; Ohl CA; Luther VP; Williamson JC
    Clin Infect Dis; 2015 Sep; 61(6):934-41. PubMed ID: 26024909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients.
    Álvarez O; Plaza-Plaza JC; Ramirez M; Peralta A; Amador CA; Amador R
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population.
    Turner RB; Kojiro K; Won R; Chang E; Chan D; Elbarbry F
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):346-351. PubMed ID: 30025969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME; Lipman J; Tett SE
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictability of serum vancomycin concentrations using the kinetic estimated glomerular filtration rate formula for critically ill patients
.
    Harada D; Uchino S; Kawakubo T; Takinami M
    Int J Clin Pharmacol Ther; 2018 Dec; 56(12):612-616. PubMed ID: 30220291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.